You are here

P&T News

March 22

Two dozen Republicans oppose the plan
Former FDA heads say imported medications are too risky
Monoamine oxidase B inhibitor approved as add-on to levodopa
Treatment debuted at annual cost of $94,500

March 21

“Per-capita caps” plan comes under fire
Days may be numbered for controversial payment initiatives
Procedure should be avoided in small heart vessels
FDA approval decision expected in April
“Blocking molecule” targets links that hold bacteria together

March 20

NKTR-181 doesn’t cause the euphoria that can lead to abuse and addiction
Twice-a-year inclisiran scores in mid-stage trial
House and Senate approval may both be at risk
Amgen and Illumina take Obamacare repeal in stride
Harvard panel hears about person-centered approaches to care

March 17

Budget blueprint trims NIH biomed spending by 20%
Analysts find HIT-related mistakes at every step of medication-use process
Monoclonal antibody reduces major cardiovascular events
Agency finds fault with manufacturing facility

Pages